Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada

BACKGROUND: Cost avoidance occurs when, because of provision of a drug therapy [drug cost avoidance (dca)] or a pathology test [pathology cost avoidance (pca)] during trial participation, health care payers need not pay for standard treatments or testing. The aim of our study was to estimate the tot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Tang, P.A., Hay, A.E., O’Callaghan, C.J., Mittmann, N., Chambers, C.R., Pater, J.L., Leighl, N.B.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780589/
https://ncbi.nlm.nih.gov/pubmed/26985151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.2861
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados